BriaCell Therapeutics Corp. 10-Q filing
Filed 2025-12-11 · Report date 2025-10-31 · 2025
Filing metadata
- Accession number
- 0001493152-25-027240
- Form type
- 10-Q
- CIK
- 0001610820
- Primary document
- https://www.sec.gov/Archives/edgar/data/1610820/000149315225027240/form10-q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BriaCell Therapeutics Corp..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-8.3M | - | - |
| Net Income | $-8.2M | - | - |
| Eps Basic | -4.35 | - | - |
| Eps Diluted | -4.35 | - | - |
| Cash And Equivalents | $2.7M | - | - |
| Total Assets | $13.1M | - | - |
| Operating Cash Flow | $-7.7M | - | - |